Evidence map›Paper›PMID 36613782›Full record

ArticleInternational journal of molecular sciences2022

Ligand-Based Drug Design of Novel Antimicrobials against

Jiqing Ye, Xiao Yang, Cong Ma

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Frontiers in cellular and infection microbiology · 2024
    Article
  6. Progress of Section "Biochemistry" in 2022.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Jiqing YeState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.ORCID 0000-0003-2461-4325
Xiao YangDepartment of Microbiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.
Cong MaState Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong SAR, China.ORCID 0000-0001-9245-0356
Hong Kong Polytechnic University · HKChinese University of Hong Kong · HK

Funding

Chinese University of Hong Kong Faculty of Medicine Faculty Innovation Award FIA2018/A/03Food and Health Bureau HMRF 20190032Hong Kong Polytechnic University 1-W18DHong Kong Polytechnic University 1-ZE2EHong Kong Polytechnic University State Key Laboratory of Chemical Biology and Drug DiscoveryInnovation and Technology Commission MRP/038/21XResearch Grants Council CUHK 14100120Research Grants Council PolyU 15100019Research Grants Council PolyU C5008-19G
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnti-Bacterial AgentsDrug DesignHumansLigandsMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsLigandsligand-based drug designpharmacophoreQSARStaphylococcus aureusvirtual screening

Identifiers

PMID36613782
PMCPMC9820117
OpenAlexW4313246349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.